Biomarker Development for Future PAC1 Antagonists With Maxadilan

Clinical trial NCT02355756 · COMPLETED

Trial details

NCT number: NCT02355756
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2015-01-01
Primary completion: 2015-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.